                         SEQUENCE LISTING

<110>  Allero Therapeutics BVBA
 
<120>  TREATMENT OF IMMUNE DISEASES BY ADMINISTRATION OF 
       ANTIGEN-SPECIFIC FORMULATIONS

<130>  P6079891PCT

<150>  EP17020500.9
<151>  2017-10-25

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Gliadin alpha1 peptide

<400>  1

Pro Phe Pro Gln Pro Glu Leu Pro Tyr 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Gliadin alpha2 peptide

<400>  2

Pro Gln Pro Glu Leu Pro Tyr Pro Gln 
1               5                   


<210>  3
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Gliadin  33-mer alpha2 peptide

<400>  3

Leu Gln Leu Gln Pro Phe Pro Gln Pro Glu Leu Pro Tyr Pro Gln Pro 
1               5                   10                  15      


Glu Leu Pro Tyr Pro Gln Pro Gln Leu Pro Tyr Pro Gln Pro Gln Pro 
            20                  25                  30          


Phe 
    


<210>  4
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DQ8d peptide

<400>  4

Gly Ala Pro Val Pro Tyr Pro Asp Pro Leu Glu Pro Arg Gln Tyr Pro 
1               5                   10                  15      


Ser Gly Glu Gly Ser Phe Gln Pro Ser Gln Glu Asn Pro Gln Ala 
            20                  25                  30      


